Patent · US Active

Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use

US8143248B2 · kind B2 · utility

5Cited by

0References

19Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Laurent Dubois · Le Plessis-Robinson, FR
Yannick Evanno · Rambouillet, FR
Luc Even · Paris, FR
Catherine Gille · Antony, FR
Andre Malanda · Paris, FR
David Machnik · Antony, FR
Nathalie Rakotoarisoa · Paris, FR

Key dates

Filing date	Aug 1, 2008
Grant date	Mar 27, 2012
Priority date	—
Expiry date	Aug 5, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns tricyclic N-heteroarylcarboxamide derivatives containing a benzimidazole unit of general formula (I):Wherein A, P, Y, R1, R2 and R3 are as defined herein. The invention also concerns a method of preparing the compounds and their therapeutic use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.